Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142387 |
| CAS No | 2492451-27-9 |
| Mol.F. | C6H13N5O3 |
| Mol.Wt. | 203.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142388 |
| CAS No | NA |
| Mol.F. | C15H20N4O3S3 |
| Mol.Wt. | 400.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142389 |
| CAS No | NA |
| Mol.F. | C13H19N3O4S |
| Mol.Wt. | 313.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142390 |
| CAS No | NA |
| Mol.F. | C12H17N3O4S |
| Mol.Wt. | 299.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142391 |
| CAS No | NA |
| Mol.F. | C15H23N3O4S |
| Mol.Wt. | 341.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142392 |
| CAS No | NA |
| Mol.F. | C15H24N4O3S |
| Mol.Wt. | 340.44 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142393 |
| CAS No | NA |
| Mol.F. | C14H21N3O4S |
| Mol.Wt. | 327.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142394 |
| CAS No | NA |
| Mol.F. | C13H19N3O4S |
| Mol.Wt. | 313.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142395 |
| CAS No | NA |
| Mol.F. | C12H17N3O4S |
| Mol.Wt. | 299.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142396 |
| CAS No | NA |
| Mol.F. | C20H17ClF2N6O4 |
| Mol.Wt. | 478.84 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142397 |
| CAS No | NA |
| Mol.F. | C16H13ClN2O3 |
| Mol.Wt. | 316.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142398 |
| CAS No | NA |
| Mol.F. | C16H13ClN2O6S |
| Mol.Wt. | 396.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142399 |
| CAS No | NA |
| Mol.F. | C16H9ClN2O2 |
| Mol.Wt. | 296.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142400 |
| CAS No | NA |
| Mol.F. | C16H14N2O2 |
| Mol.Wt. | 266.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142401 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O2 |
| Mol.Wt. | 302.76 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142402 |
| CAS No | NA |
| Mol.F. | C16H14N2O2 |
| Mol.Wt. | 266.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |